Neuropathology of preclinical and clinical lateonset Alzheimer's disease
暂无分享,去创建一个
J E Smialek | B. Crain | C. Kawas | J. Troncoso | L. Martin | F. Checler | R. Nixon | J. Smialek | Michael K. Lee | L. J. Martin | D. Fowler | R A Nixon | L J Martin | A. Cataldo | J. Barnett | M. Lee | J C Troncoso | F Checler | B Crain | A M Cataldo | J L Barnett | M K Lee | D R Fowler | C H Kawas | Barbara Crain | David R. Fowler | Rallph A. Nixon | Barbara J. Crain | David Fowler
[1] R. Mrak,et al. Interleukin‐1 Expression in Different Plaque Types in Alzheimer's Disease: Significance in Plaque Evalution , 1995, Journal of neuropathology and experimental neurology.
[2] L. Berg,et al. Clinical Dementia Rating , 1984, British Journal of Psychiatry.
[3] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[4] K. Davis,et al. A Study of the Reliability of the Family History Method in Genetic Sudies of Alzheimer Disease , 1989, Alzheimer disease and associated disorders.
[5] D. Mann,et al. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in down Syndrome , 1995, Annals of neurology.
[6] P. Matsudaira,et al. Generation of beta-amyloid in the secretory pathway in neuronal and nonneuronal cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Nixon,et al. Increased Neuronal Endocytosis and Protease Delivery to Early Endosomes in Sporadic Alzheimer’s Disease: Neuropathologic Evidence for a Mechanism of Increased β-Amyloidogenesis , 1997, The Journal of Neuroscience.
[8] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[9] N. Robakis,et al. Evidence that secretase cleavage of cell surface Alzheimer amyloid precursor occurs after normal endocytic internalization , 1995, Journal of neuroscience research.
[10] D. Selkoe,et al. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.
[11] T. Tabira,et al. Demonstration of amyloid β-protein secretion in a mouse neuronal cell line , 1994, Neuroscience Letters.
[12] D. Dickson,et al. A neuronal antigen in the brains of Alzheimer patients. , 1986, Science.
[13] R. Nixon,et al. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[14] Jinhe Li,et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system , 1995, Neuron.
[15] J. Buxbaum,et al. Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins and the Immunohistochemistry of Sporadic Alzheimer’s Disease and Cerebral Amyloid Angiopathy Cases , 1997, Molecular medicine.
[16] S. Squazzo,et al. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.
[17] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[18] A. Hirano,et al. A COMPARATIVE STUDY OF MODIFIED BIELSCHOWSKY, BODIAN AND THIOFLAVIN S STAINS ON ALZHEIMER'S NEUROFIBRILLARY TANGLES , 1986, Neuropathology and applied neurobiology.